Harry Glorikian at Medco's 2011 Drug Trend Symposium
Conferences
Scientia Advisors Participates to Session on Examining Personalized Medicine at Medco's 2011 Drug Trend Symposium
Topic
Examining Personalized Medicine: Managing the growth of genetic testingOver the next decade, we will see a continued explosion in genetic tests and diagnostic tools that are designed to help physicians and patients make more informed treatment decisions and take preventive action. You will need effective strategies to ensure you are managing costs and care effectively. This session will highlight the opportunities and tools needed to manage this evolving aspect of healthcare, including policy development and management, utilization management strategies, and decision-making tools for patients and physicians, as well as applications of genetic testing and wellness strategies.
Speakers
- Michael J. Barone - Senior Vice President, General Manager, Health Plans-Central and Western Regions, Medco
- Trisha Brown, M.S., CGC - Vice President, Clinical Affairs, DNA Direct by Medco
- Harry Glorikian - Managing Partner, Scientia Advisors
- Howard Levy, M.D., Ph.D. - Assistant Professor, Department of Medicine & McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University
- Carole Mendoza, CEBS - Benefits Leader, Global Human Resources, Life Technologies
More information at the 2011 Drug Trend Symposium Website.
EVENT INFORMATION »
Date: May 19, 2011
Location:
Lake Buena Vista, FL
Hosted by:
Medco
Registration Information:
By invitation only
SCIENTIA ADVISORS, LLC | info@scientiaadv.com
55 Cambridge Parkway, Suite 300E, Cambridge MA 02142 | Phone: 617-299-3000 | Fax: 617-812-0315
© 2012 Scientia Advisors LLC
